Cited by 3,162Cancer Genomics and DiagnosticsCancer Cells and MetastasisEvolution and Genetic Dynamics

The DOI matches its Crossref record; 104 of the 107 references it cites were found in a registry or an index, and 3 are not checked yet.

Clonal evolution in cancer

Open access

Greaves, Mel, Maley, Carlo C.·2012·Nature

DOI 10.1038/nature10762PMC PMC3367003

Open this paper in CoChat — free account

Abstract

Cancers evolve by a reiterative process of clonal expansion, genetic diversification and clonal selection within the adaptive landscapes of tissue ecosystems. The dynamics are complex, with highly variable patterns of genetic diversity and resulting clonal architecture. Therapeutic intervention may destroy cancer clones and erode their habitats, but it can also inadvertently provide a potent selective pressure for the expansion of resistant variants. The inherently Darwinian character of cancer is the primary reason for this therapeutic failure, but it may also hold the key to more effective control.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature10762

Cites

104 of 107 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cancer Statistics, 2008
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Tumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Önder, T. T., Jiang, G., Tao, K. X., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,429
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253

Flagged first, then by citations

Show all 104 references

Sorted by citations

Items 601–700 of 1,004

Emerging strategies to investigate the biology of early cancer
Zhou, R., Tang, X., & Wang, Y. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00754-y · Cited by 72
Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression
Yu, S., Cai, X., Wu, C., Wu, L., Wang, Y., Liu, Y., Yu, Z., Qin, S., Ma, F., Thiery, J. P., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3095 · Cited by 69
Heat shock protein DNAJB 8 is a novel target for immunotherapy of colon cancer‐initiating cells
Morita, R., Nishizawa, S., Torigoe, T., Takahashi, A., Tamura, Y., Tsukahara, T., Kanaseki, T., Sokolovskaya, A., Kochin, V., Kondo, T., et al. (2014) · Cancer Science · doi:10.1111/cas.12362 · Cited by 68
Evolutionary game theory of growth factor production: implications for tumour heterogeneity and resistance to therapies
Archetti, M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.336 · Cited by 68
High-SensitivityBRAFMutation Analysis:BRAFV600E Is Acquired Early During Tumor Development but Is Heterogeneously Distributed in a Subset of Papillary Thyroid Carcinomas
de Biase, D., Cesari, V., Visani, M., Casadei, G. P., Cremonini, N., Gandolfi, G., Sancisi, V., Ragazzi, M., Pession, A., Ciarrocchi, A., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4389 · Cited by 68
The Zebrafish Xenograft Platform: Evolution of a Novel Cancer Model and Preclinical Screening Tool
Wertman, J. N., Veinotte, C. J., Dellaire, G., & Berman, J. N. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-30654-4_13 · Cited by 70
Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells
Jo, Y. K., Roh, S. A., Lee, H., Park, N. Y., Choi, E. S., Oh, J., Park, S. J., Shin, J. H., Suh, Y., Lee, E. K., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.002 · Cited by 66
The Line-drawing Problem in Disease Definition
Rogers, W., & Walker, M. J. (2017) · The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine · doi:10.1093/jmp/jhx010 · Cited by 68
Harnessing Tumor Evolution to Circumvent Resistance
McNamara, K. L., & Curtis, C. N. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.05.007 · Cited by 70
SubClonal Hierarchy Inference from Somatic Mutations: Automatic Reconstruction of Cancer Evolutionary Trees from Multi-region Next Generation Sequencing
Niknafs, N., Guthrie, V. B., Naiman, D. Q., & Karchin, R. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004416 · Cited by 68
Intratumor heterogeneity reflects clinical disease course
Iacobuzio–Donahue, C. A., Litchfield, K., & Swanton, C. (2020) · Nature Cancer · doi:10.1038/s43018-019-0002-1 · Cited by 66
Evolutionary dynamics at the tumor edge reveal metabolic imaging biomarkers
Jiménez-Sánchez, J., Bosque, J. J., Londoño, G. A. J., Molina-García, D., Martínez, Á., Pérez-Beteta, J., Ortega-Sabater, C., Martínez, A. F. H., Vicente, A. M. G., Calvo, G. F., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2018110118 · Cited by 67
Utilization of Functionalized Metal–Organic Framework Nanoparticle as Targeted Drug Delivery System for Cancer Therapy
Tran, V. A., Le, V. T., Doan, V., & Vo, G. N. L. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030931 · Cited by 69
Oxidative stress-induced mutagenesis in single-strand DNA occurs primarily at cytosines and is DNA polymerase zeta-dependent only for adenines and guanines
Degtyareva, N. P., Heyburn, L., Sterling, J., Resnick, M. A., Gordenin, D. A., & Doetsch, P. W. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt671 · Cited by 67
Concise Review: Crosstalk of Mesenchymal Stroma/Stem-Like Cells with Cancer Cells Provides Therapeutic Potential
Melzer, C., von der Ohe, J., & Hass, R. (2018) · Stem Cells · doi:10.1002/stem.2829 · Cited by 70
HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity
Prince, T. L., Lang, B. J., Guerrero-Gimenez, M. E., Fernandez-Muñoz, J. M., Ackerman, A., & Calderwood, S. K. (2020) · Cells · doi:10.3390/cells9041046 · Cited by 67
Single-cell analysis based dissection of clonality in myelofibrosis
Mylonas, E., Yoshida, K., Frick, M., Hoyer, K., Christen, F., Kaeda, J., Obenaus, M., Noerenberg, D., Hennch, C., Chan, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13892-x · Cited by 72
Microenvironmental control of stem cell fate in intestinal homeostasis and disease
Biswas, S., Belnoue-Davis, H. L., Irshad, S., Sandberg, T. P., Worthley, D. L., & Leedham, S. J. (2015) · The Journal of Pathology · doi:10.1002/path.4563 · Cited by 66
The MET Oncogene in Glioblastoma Stem Cells: Implications as a Diagnostic Marker and a Therapeutic Target
Boccaccio, C., & Comoglio, P. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4039 · Cited by 66
NSAIDs Modulate Clonal Evolution in Barrett's Esophagus
Kostadinov, R. L., Kuhner, M. K., Li, X., Sanchez, C. A., Galipeau, P. C., Paulson, T. G., Sather, C. L., Srivastava, A., Odze, R. D., Blount, P. L., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003553 · Cited by 66
Self-citation
SCL, LMO1 and Notch1 Reprogram Thymocytes into Self-Renewing Cells
Gerby, B., Tremblay, C., Tremblay, M., Rojas-Sutterlin, S., Herblot, S., Hébert, J., Sauvageau, G., Lemieux, S., Lécuyer, E., Veiga, D. F. T., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004768 · Cited by 66
The Cancer Stem Cell Fraction in Hierarchically Organized Tumors Can Be Estimated Using Mathematical Modeling and Patient-Specific Treatment Trajectories
Werner, B., Scott, J. G., Sottoriva, A., Anderson, A. R. A., Traulsen, A., & Altrock, P. M. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2069 · Cited by 62
Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML
Valent, P., Kern, W., Hoermann, G., Feenstra, J. D. M., Sotlar, K., Pfeilstöcker, M., Germing, U., Sperr, W. R., Reiter, A., Wolf, D. G. F., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030789 · Cited by 68
Antibiotics can be used to contain drug-resistant bacteria by maintaining sufficiently large sensitive populations
Hansen, E., Karslake, J., Woods, R. J., Read, A. F., & Wood, K. B. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000713 · Cited by 66
Intratumor heterogeneity in epigenetic patterns
Assenov, Y., Brocks, D., & Gerhäuser, C. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.01.010 · Cited by 67
Adaptive response of resistant cancer cells to chemotherapy
Chern, Y., & Tai, I. T. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0005 · Cited by 67
The end of the genetic paradigm of cancer
Huang, S., Soto, A. M., & Sonnenschein, C. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003052 · Cited by 68
The evolution of the unstable cancer genome
Burrell, R. A., & Swanton, C. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.011 · Cited by 66
Nonheritable Cellular Variability Accelerates the Evolutionary Processes of Cancer
Frank, S. A., & Rosner, M. R. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001296 · Cited by 65
Toward precision medicine of breast cancer
Carels, N., Spinassé, L. B., Tilli, T. M., & Tuszyński, J. A. (2016) · Theoretical Biology and Medical Modelling · doi:10.1186/s12976-016-0035-4 · Cited by 65
Recruitment of Pontin/Reptin by E2f1 amplifies E2f transcriptional response during cancer progression
Tarangelo, A., Lo, N., Teng, R. S. Y., Kim, E., Le, L., Watson, D. J., Furth, E. E., Raman, P., Ehmer, U., & Viatour, P. (2015) · Nature Communications · doi:10.1038/ncomms10028 · Cited by 65
The Origins of Gastric Cancer From Gastric Stem Cells: Lessons From Mouse Models
Hayakawa, Y., Fox, J. G., & Wang, T. C. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.01.013 · Cited by 69
Gain of HIF-1α under Normoxia in Cancer Mediates Immune Adaptation through the AKT/ERK and VEGFA Axes
Lee, Y.-H., Bae, H. C., Noh, K. H., Song, K.-H., Ye, S.-K., Mao, C.-P., Lee, K.-M., Wu, T.-C., & Kim, T. W. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1979 · Cited by 64
Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis
Neelakantan, D., Drasin, D. J., & Ford, H. L. (2014) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.972761 · Cited by 64
The role of mitochondrial electron transport in tumorigenesis and metastasis
Tan, A. S., Baty, J. W., & Berridge, M. V. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.016 · Cited by 65
Clonal cooperativity in heterogenous cancers
Zhou, H., Neelakantan, D., & Ford, H. L. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.028 · Cited by 66
“Energetic” Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy
Fiorillo, M., Sotgia, F., & Lisanti, M. P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00677 · Cited by 64
Identification and characterization
Bernstein, J., & Reutzel‐Edens, S. M. (2019) · urn:isbn:978-1-118-41628-0 · Cited by 112
Cancer stem cells display extremely large evolvability: alternating plastic and rigid networks as a potential Mechanism
Csermely, P., Hódsági, J., Korcsmáros, T., Módos, D., Perez-Lopez, Á. R., Szalay, K. Z., Veres, D. V., Lenti, K., Wu, L., & Zhang, X.-S. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.004 · Cited by 63
Improving cancer treatments via dynamical biophysical models
Kuznetsov, M. B., Clairambault, J., & Volpert, V. A. (2021) · Physics of Life Reviews · doi:10.1016/j.plrev.2021.10.001 · Cited by 64
Tumor Heterogeneity Confounds and Illuminates: A case for Darwinian tumor evolution
Polyák, K. (2014) · Nature Medicine · doi:10.1038/nm.3518 · Cited by 64
Unilateral Breast Cancer: Screening of Contralateral Breast by Using Preoperative MR Imaging Reduces Incidence of Metachronous Cancer
Kim, J. Y., Cho, N., Koo, H. R., Yi, A., Kim, W. H., Lee, S. H., Chang, J. M., Han, W., Moon, H., Im, S., et al. (2013) · Radiology · doi:10.1148/radiol.12120629 · Cited by 63
Metronomic Chemotherapy: Direct Targeting of Cancer Cells after all?
André, N., Tsai, K. K., Carré, M., & Pasquier, E. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.03.011 · Cited by 63
Treatment resistance in urothelial carcinoma: an evolutionary perspective
Vlachostergios, P. J., & Faltas, B. M. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0026-y · Cited by 62
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases
Romei, C., Ciampi, R., Casella, F., Tacito, A., Torregrossa, L., Ugolini, C., Basolo, F., Materazzi, G., Vitti, P., & Elisei, R. (2018) · Oncotarget · doi:10.18632/oncotarget.23986 · Cited by 62
Understanding the Cause and Consequence of Tumor Heterogeneity
Khatib, S. A., Pomyen, Y., Dang, H. T., & Wang, X. W. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.01.010 · Cited by 65
Optimal control to reach eco-evolutionary stability in metastatic castrate-resistant prostate cancer
Cunningham, J. J., Thuijsman, F., Peeters, R., Viossat, Y., Brown, J. S., Gatenby, R. A., & Staňková, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243386 · Cited by 61
Single cell metabolism: current and future trends
Ali, A., Davidson, S. M., Fraenkel, E., Gilmore, I. S., Hankemeier, T., Kirwan, J., Lane, A. N., Lanekoff, I., Larion, M., McCall, L., et al. (2022) · Metabolomics · doi:10.1007/s11306-022-01934-3 · Cited by 64
SCL/TAL1 in Hematopoiesis and Cellular Reprogramming
Hoang, T., Lambert, J. A., & Martin, R. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.01.004 · Cited by 68
Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer
Gatenby, R. A., & Brown, J. S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.03.005 · Cited by 62
Addressing the challenges of applying precision oncology
Shin, S. H., Bode, A. M., & Dong, Z. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0032-z · Cited by 65
The value of monitoring to control evolving populations
Fischer, A., Vázquez-Garćıa, I., & Mustonen, V. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409403112 · Cited by 63
Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo
Klevebring, D., Rosin, G., Ma, R., Lindberg, J., Czene, K., Kere, J., Fredriksson, I., Bergh, J. C. S., & Hartman, J. (2014) · Breast Cancer Research · doi:10.1186/bcr3687 · Cited by 61
Nuclear factor one transcription factors as epigenetic regulators in cancer
Fane, M. E., Harris, L., Smith, A. G., & Piper, M. (2017) · International Journal of Cancer · doi:10.1002/ijc.30603 · Cited by 63
Implications of KRAS mutations in acquired resistance to treatment in NSCLC
Re, M. D., Rofi, E., Restante, G., Crucitta, S., Arrigoni, E., Fogli, S., Maïo, M. D., Petrini, I., & Danesi, R. (2017) · Oncotarget · doi:10.18632/oncotarget.23553 · Cited by 64
Therapy-induced polyploidization and senescence: Coincidence or interconnection?
Sikora, E., Czarnecka‐Herok, J., Bojko, A., & Sunderland, P. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.015 · Cited by 65
Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology
Workman, P., Al‐Lazikani, B., & Clarke, P. A. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.06.004 · Cited by 60
Liquid biopsy in pancreatic cancer: the beginning of a new era
Yadav, D. K., Bai, X., Yadav, R. K., Singh, A., Li, G., Ma, T., Chen, W., & Liang, T. (2018) · Oncotarget · doi:10.18632/oncotarget.24809 · Cited by 62
Molecular docking, synthesis and anticancer activity of thiosemicarbazone derivatives against MCF-7 human breast cancer cell line
Sibuh, B. Z., Khanna, S., Taneja, P., Sarkar, P., & Taneja, N. K. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119305 · Cited by 66
Precision Oncology Beyond Genomics: The Future Is Here—It Is Just Not Evenly Distributed
Pfohl, U., Pflaume, A., Regenbrecht, M., Finkler, S., Adelmann, Q. G., Reinhard, C., Regenbrecht, C. R. A., & Wedeken, L. (2021) · Cells · doi:10.3390/cells10040928 · Cited by 68
Paradigm shift in oncology: targeting the immune system rather than cancer cells
Shekarian, T., Valsesia‐Wittmann, S., Caux, C., & Marabelle, A. (2015) · Mutagenesis · doi:10.1093/mutage/geu073 · Cited by 64
Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes
Hsu, J., Reilly, A., Hayes, B. J., Clough, C. A., Konnick, E. Q., Torok‐Storb, B., Gülsüner, S., Wu, D., Becker, P. S., Keel, S., et al. (2019) · Blood · doi:10.1182/blood.2018884338 · Cited by 63
CRISPR-cas9: a powerful tool towards precision medicine in cancer treatment
Xing, H., & Meng, L. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0322-9 · Cited by 61
The evolution of hematopoietic cells under cancer therapy
Pich, O., Cortés‐Bullich, A., Muiños, F., Pratcorona, M., González-Pérez, A., & López-Bigas, N. (2021) · Nature Communications · doi:10.1038/s41467-021-24858-3 · Cited by 60
Reconciling Non-Genetic Plasticity with Somatic Evolution in Cancer
Huang, S. (2021) · Trends in cancer · doi:10.1016/j.trecan.2020.12.007 · Cited by 60
Evolution via somatic genetic variation in modular species
Reusch, T. B. H., Baums, I. B., & Werner, B. (2021) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2021.08.011 · Cited by 65
Cancer Evo–Dev: A Theory of Inflammation-Induced Oncogenesis
Liu, W., Deng, Y., Li, Z., Chen, Y., Zhu, X., Tan, X., & Cao, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.768098 · Cited by 63
Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment
Kilmister, E. J., Koh, S. P., Weth, F. R., Gray, C., & Tan, S. T. (2022) · Biomedicines · doi:10.3390/biomedicines10112988 · Cited by 61
Hypoxia-Induced Reactive Oxygen Species: Their Role in Cancer Resistance and Emerging Therapies to Overcome It
Mendoza, E. N., Ciriolo, M. R., & Ciccarone, F. (2025) · Antioxidants · doi:10.3390/antiox14010094 · Cited by 65
Tracking cells in their native habitat: lineage tracing in epithelial neoplasia
Alcolea, M. P., & Jones, P. H. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3460 · Cited by 58
Computational pathology: Exploring the spatial dimension of tumor ecology
Nawaz, S., & Yuan, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.018 · Cited by 62
The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care
Rosa, M. D., Rega, D., Costabile, V., Duraturo, F., Niglio, A., Izzo, P., Pace, U., & Delrio, P. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16659790 · Cited by 61
Drosophila As a Cancer Model
Enomoto, M., Siow, K. M., & Igaki, T. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0529-0_10 · Cited by 63
Homeostasis Back and Forth: An Ecoevolutionary Perspective of CancerPreprint
Basanta, D., & Anderson, A. R. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028332 · Cited by 58
Identifying and Quantifying Heterogeneity in High Content Analysis: Application of Heterogeneity Indices to Drug Discovery
Gough, A., Chen, N., Shun, T. Y., Lezon, T. R., Boltz, R. C., Reese, C. E., Wagner, J., Vernetti, L. A., Grandis, J. R., Lee, A. V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102678 · Cited by 61
Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes
Feeney, L., Harley, I. J. G., McCluggage, W. G., Mullan, P. B., & Beirne, J. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i11.868 · Cited by 62
Mutational Landscape and Evolutionary Pattern of Liver and Brain Metastasis in Lung Adenocarcinoma
Jiang, T., Fang, Z., Tang, S., Cheng, R., Li, Y., Ren, S., Su, C., Min, W., Guo, X., Zhu, W., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.10.128 · Cited by 60
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes
Meister, M. T., Koerkamp, M. J. A. G., de Souza, T. M., Breunis, W. B., Frazer‐Mendelewska, E., Brok, M. O., DeMartino, J., Manders, F., Calandrini, C., Kerstens, H. H. D., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216001 · Cited by 57
Molecular Aspects of Head and Neck Cancer Therapy
Puram, S. V., & Rocco, J. W. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.07.003 · Cited by 58
Adaptive Resistance to an Inhibitor of Chromosomal Instability in Human Cancer Cells
Orr, B., Talje, L., Liu, Z., Kwok, B. H. B., & Compton, D. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.030 · Cited by 57
DNA helix: the importance of being AT-rich
Vinogradov, A. E., & Anatskaya, O. V. (2017) · Mammalian Genome · doi:10.1007/s00335-017-9713-8 · Cited by 61
Investigations into the cancer stem cell niche using in-vitro 3-D tumor models and microfluidics
Sreepadmanabh, M., & Toley, B. J. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.009 · Cited by 58
Clonal dynamics in osteosarcoma defined by RGB marking
Gambera, S., Abarrategi, A., González‐Camacho, F., Morales‐Molina, Á., Roma, J. M., Alfranca, A., & Garcı́a-Castro, J. (2018) · Nature Communications · doi:10.1038/s41467-018-06401-z · Cited by 56
The Cancer Stem Cell in Hepatocellular Carcinoma
Schulte, L.-A., López-Gil, J. C., Sáinz, B., & Hermann, P. C. (2020) · Cancers · doi:10.3390/cancers12030684 · Cited by 59
Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma
Akgül, S., Patch, A.-M., D’Souza, R. C. J., Mukhopadhyay, P., Nones, K., Kempe, S., Kazakoff, S. H., Jeffree, R. L., Stringer, B. W., Pearson, J. V., et al. (2019) · Cancers · doi:10.3390/cancers11020190 · Cited by 57
Concepts in solid tumor evolution
Sidow, A., & Spies, N. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.02.001 · Cited by 60
Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia
Ojha, J., Ayres-Silva, J. D. P., Secreto, C. R., Tschumper, R. C., Rabe, K. G., Dyke, D. L. V., Slager, S. L., Shanafelt, T. D., Fonseca, R., Kay, N. E., et al. (2014) · Blood · doi:10.1182/blood-2014-06-580563 · Cited by 57
Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy
Papadaki, S., & Magklara, A. (2022) · Cancers · doi:10.3390/cancers14235912 · Cited by 62
Lung cancer stem cells: Molecular features and therapeutic targets
Singh, S., & Chellappan, S. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.08.003 · Cited by 57
A Novel Intravital Imaging Window for Longitudinal Microscopy of the Mouse Ovary
Bochner, F., Fellus-Alyagor, L., Kalchenko, V., Shinar, S., & Neeman, M. (2015) · Scientific Reports · doi:10.1038/srep12446 · Cited by 57
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX
Sotgia, F., Ózsvári, B., Fiorillo, M., Francesco, E. M. D., Bonuccelli, G., & Lisanti, M. P. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1515551 · Cited by 57
Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma
Lin, L., & Lin, D. (2019) · Cancers · doi:10.3390/cancers11081156 · Cited by 58
On‐Demand Droplet Collection for Capturing Single Cells
Nan, L., Lai, M. Y. A., Tang, M. Y. H., Chan, Y. K., Poon, L. L. M., & Shum, H. C. (2019) · Small · doi:10.1002/smll.201902889 · Cited by 57
Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers
El-Aziz, Y. S. A., Spillane, A. J., Jansson, P. J., & Sahni, S. (2021) · Bioscience Reports · doi:10.1042/bsr20204092 · Cited by 56
Balancing DNA repair to prevent ageing and cancer
Stead, E. R., & Bjedov, I. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112679 · Cited by 62
Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?
Leblanc, V., & Marra, M. A. (2015) · Cancers · doi:10.3390/cancers7030869 · Cited by 57
Platelet-derived Growth Factor Primes Cancer-associated Fibroblasts for Apoptosis
Ilyas, S. I., Mertens, J. C., Bronk, S. F., Hirsova, P., Dai, H., Roberts, L. R., Kaufmann, S. H., & Gores, G. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.563064 · Cited by 56
Deep sequencing as a probe of normal stem cell fate and preneoplasia in human epidermis
Simons, B. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516123113 · Cited by 57
Single‐cell profiling approaches to probing tumor heterogeneity
Khoo, B. L., Chaudhuri, P. K., Ramalingam, N., Tan, D. S. W., Lim, C. T., & Warkiani, M. E. (2016) · International Journal of Cancer · doi:10.1002/ijc.30006 · Cited by 57
Machine Learning-Assisted Network Inference Approach to Identify a New Class of Genes that Coordinate the Functionality of Cancer Networks
Bari, M. G., Ung, C. Y., Zhang, C., Zhu, S., & Li, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-07481-5 · Cited by 57

Authors: Greaves, M., & Maley, C. C.
Affiliations: University of California, San Francisco (US)
ORCID: Maley, Carlo C.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2012-01
Volume: 481
Issue: 7381
Pages: 306-313
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature10762
PMC: PMC3367003
OpenAlex: W2023560061
Cited by: 3,162
References: 104
Citations by year: 2026: 180 · 2025: 160 · 2024: 181 · 2023: 225 · 2022: 204 · 2021: 253 · 2020: 229 · 2019: 211 · 2018: 247 · 2017: 296 · 2016: 247 · 2015: 238 · 2014: 221 · 2013: 164 · 2012: 101
FWCI: 17.27
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Cancer Institute (R01CA149566, P01CA091955, U54CA143803, P01CA91955, R01CA140657)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords: clonal evolution, cancer, clonal expansion, genetic diversification, clonal selection, fitness landscape, tumor microenvironment, clonal architecture, drug resistance
MeSH terms: Animals, Clone Cells, Humans, Mutation, Neoplasms, Neoplastic Stem Cells, Genomics, Tumor Microenvironment, Clonal Evolution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clonal evolution in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks